Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

PharmaCyte Biotech (PMCB) Times Interest Earned (2016 - 2022)

PharmaCyte Biotech (PMCB) has disclosed Times Interest Earned for 11 consecutive years, with $544.95 as the latest value for Q1 2022.

  • On a quarterly basis, Times Interest Earned rose 117.93% to $544.95 in Q1 2022 year-over-year; TTM through Oct 2022 was $4050.3, a 457.21% increase, with the full-year FY2022 number at -$8628.7, down 625.45% from a year prior.
  • Times Interest Earned was $544.95 for Q1 2022 at PharmaCyte Biotech, up from -$622.97 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $544.95 in Q1 2022 to a low of -$3039.5 in Q1 2021.
  • A 3-year average of -$1454.3 and a median of -$1529.0 in 2020 define the central range for Times Interest Earned.
  • Peak YoY movement for Times Interest Earned: rose 3.57% in 2021, then soared 117.93% in 2022.
  • PharmaCyte Biotech's Times Interest Earned stood at -$1402.5 in 2020, then skyrocketed by 55.58% to -$622.97 in 2021, then soared by 187.48% to $544.95 in 2022.
  • Per Business Quant, the three most recent readings for PMCB's Times Interest Earned are $544.95 (Q1 2022), -$622.97 (Q4 2021), and -$2191.3 (Q3 2021).